Photo of Markwayne Mullin
R United States Senate · Oklahoma

Sen. Markwayne Mullin

Compare
Total votes
1,513
all sessions
Attendance
96%
53 missed
Lower than 77% of chamber peers
With party
94%
of cast votes
Near the chamber average
Bipartisan score
3%
crosses aisle rarely
Lower than 76% of chamber peers
Sponsored
807
bills & resolutions
Lower than 93% of chamber peers
Committees
0
assignments
807 bills and resolutions

Sponsored bills

Total
807
Primary
70
Co-sponsor
737
This page
807
matching current filters
Co-sponsor HR 6397
In committee · United States House · Co-sponsor
Medical Student Education Authorization Act of 2022

Medical Student Education Authorization Act of 2022 This bill establishes matching grants awarded by the Health Resources and Services Administration (HRSA) to expand and support medical education with a particular focus on training students to serve as primary care physicians in tribal, rural, or medically underserved communities. HRSA must award the grants to public institutions of higher education located in states that rank in the top quartile of states based on projected unmet demand for primary care providers. In awarding the grants, HRSA must give priority to recipients that (1) are located in states with two or more federally recognized Indian tribes, and (2) demonstrate a public-private partnership. Recipients must use grant funds for specified activities that include developing curricula, expanding partnerships with health care providers and community-based organizations, and providing scholarships.

In committee Jan 14, 2022 1 co-sponsor
Co-sponsor HR 3537
Signed into law · United States House · Co-sponsor
Accelerating Access to Critical Therapies for ALS Act

Accelerating Access to Critical Therapies for ALS Act This bill establishes grant programs to address neurodegenerative diseases, such as amyotrophic lateral sclerosis (also known as ALS or Lou Gehrig's disease), and contains other related provisions. The Department of Health and Human Services (HHS) shall award grants to eligible entities for scientific research utilizing data from expanded access to investigational ALS treatments for individuals who are not otherwise eligible for clinical trials.  The Food and Drug Administration (FDA) shall award grants to public and private entities to cover the costs of research and development of drugs that diagnose or treat ALS and other rare neurodegenerative diseases. HHS shall also establish the Public-Private Partnership for Neurodegenerative Diseases between the National Institutes of Health, the FDA, and at least one eligible entity (generally, an institution of higher education or a nonprofit organization). The partnership shall support the development and regulatory review of drugs that address ALS and other rare neurodegenerative diseases. The FDA shall publish on its website a five-year action plan for fostering the development of drugs that improve or extend the lives of people living with rare neurodegenerative diseases. The Government Accountability Office must report to Congress about the grants provided under this bill, including an analysis of the impact of such grants on research and development of treatments for ALS.

Signed into law Dec 23, 2021 1 co-sponsor
Co-sponsor HR 6321
In committee · United States House · Co-sponsor
Answer COVID FOIAs Now Act

Answer COVID FOIAs Now Act This bill addresses pending Freedom of Information Act (FOIA) requests related to COVID-19. Specifically, the bill requires each federal agency, within 100 calendar days, to complete all pending FOIA requests related to a drug or medical device to prevent, diagnose, mitigate, or treat COVID-19; gain-of-function or potential pandemic pathogen research; or a policy, rule, or standard requiring COVID-19 vaccination of individuals. For each calendar day on which any applicable FOIA request remains pending, the Department of the Treasury must transfer $1 million from the appropriations account of the office of the head of the agency to the Countermeasures Injury Compensation Program of the Health Resources and Services Administration. A person submitting such a request shall be deemed to have demonstrated a compelling need for expedited processing.

In committee Dec 16, 2021 1 co-sponsor
Co-sponsor HR 5142
Signed into law · United States House · Co-sponsor
To award posthumously a Congressional Gold Medal, in commemoration to the servicemembers who perished in Afghanistan on August 26, 2021, during the evacuation of citizens of the United States and Afghan allies at Hamid Karzai International Airport, and for other purposes.

This bill posthumously provides for the award of a Congressional Gold Medal in commemoration of the 13 service members who died on August 26, 2021, while stationed at Hamid Karzai International Airport in Afghanistan.

Signed into law Dec 16, 2021 1 co-sponsor
Co-sponsor HR 6235
In committee Dec 10, 2021 1 co-sponsor
Co-sponsor HR 6202
In committee · United States House · Co-sponsor
Telehealth Extension Act of 2021

Telehealth Extension Act of 2021 This bill expands and otherwise modifies coverage of telehealth services under Medicare. Specifically, the bill permanently (1) removes geographic restrictions on originating sites (i.e., the location of the beneficiary), (2) allows the home of the beneficiary to serve as the originating site for all services, and (3) allows federally qualified health centers and rural health clinics to serve as the distant site (i.e., the location of the health care practitioner). The bill also extends any Medicare telehealth flexibilities that were granted during the COVID-19 public health emergency until two years after the emergency ends and generally allows such flexibilities to be granted during any public health emergency. In addition, the bill (1) allows for Medicare payment of outpatient critical access hospital services consisting of telehealth behavioral therapy until two years after the COVID-19 public health emergency ends; and (2) after the emergency ends, conditions payment for certain high-cost laboratory tests and durable medical equipment that are ordered via telehealth on at least one in-person visit during the preceding six-month period.

In committee Dec 10, 2021 1 co-sponsor
Co-sponsor HR 5487
Passed · United States House · Co-sponsor
SHINE for Autumn Act of 2021

Stillbirth Health Improvement and Education for Autumn Act of 2021 or the SHINE for Autumn Act of 2021 This bill authorizes grants and establishes other programs to improve data collection on stillbirths. Specifically, the Department of Health and Human Services (HHS) may award grants for surveillance and data collection on stillbirths, and HHS must issue guidelines for health departments and vital statistics units concerning the collection of stillbirth data. HHS must also develop educational awareness materials about stillbirths and make them publicly available. Furthermore, HHS must implement a fellowship program to provide training in perinatal autopsy pathology and otherwise support research on stillbirths and fetal autopsies. The bill also requires HHS to issue a report with educational guidelines on stillbirths and stillbirth risk factors.

Passed Dec 9, 2021 1 co-sponsor
Co-sponsor HR 2074
Passed · United States House · Co-sponsor
Indian Buffalo Management Act

Indian Buffalo Management Act This bill establishes a permanent program within the Department of the Interior to develop and promote tribal ownership and management of buffalo and buffalo habitat on Indian lands. Specifically, the bill requires Interior to (1) enter into contracts, award grants, and provide technical assistance to Indian tribes and tribal organizations for activities related to buffalo restoration or management; (2) consult with tribes and tribal organizations on initiatives that affect buffalo or buffalo habitat, including efforts to contain or eradicate diseased buffalo; and (3) develop a policy relating to buffalo and buffalo habitat management activities on Indian land. Additionally, Interior may enter into agreements with tribes or tribal organizations to transport surplus buffalo from federal land onto Indian land.

Passed Dec 9, 2021 1 co-sponsor
Co-sponsor HR 6178
In committee · United States House · Co-sponsor
To prohibit the Department of Defense from discharging or withholding pay or benefits from members of the National Guard based on COVID-19 vaccination status.

This bill prohibits the Department of Defense (DOD) from taking specified actions against a member of the National Guard based on whether the member has received a COVID-19 vaccine. Specifically, DOD may not (1) involuntarily discharge or discipline the member, (2) withhold pay or benefits from the member, or (3) prohibit the member from participating in training or using equipment.

In committee Dec 8, 2021 1 co-sponsor
Co-sponsor HR 6160
In committee · United States House · Co-sponsor
Access to Rare Indications Act of 2021

Access to Rare Indications Act of 2021 This bill provides for coverage under the Medicare prescription drug benefit, Medicaid, and private health insurance of certain drugs that are used to treat rare diseases or conditions (i.e., diseases or conditions that affect 200,000 or fewer individuals). Such drugs must be supported by peer-reviewed research or medical experts and must not have been reviewed unfavorably in specified compendia or used in a way that conflicts with approved labels.

In committee Dec 8, 2021 1 co-sponsor
Showing 601 to 610 of 807 bills
Previous 1 … 60 61 62 … 81 Next